HSK7653

DRUG2 trials

Sponsors

Haisco Pharmaceutical Group Co., Ltd.

Conditions

T2DM (Type 2 Diabetes Mellitus)Type 2 Diabetes Mellitus

Phase 1

Single Escalating Dose Study Of HSK7653 In Healthy Subjects

CompletedNCT05983289

Haisco Pharmaceutical Group Co., Ltd.T2DM (Type 2 Diabetes Mellitus)

Start: 2018-05-08End: 2019-07-03Updated: 2023-08-09

A Study to Evaluate the DDI of HSK7653 With Metformin

CompletedNCT06084156

Haisco Pharmaceutical Group Co., Ltd.Type 2 Diabetes Mellitus

Start: 2019-08-10End: 2019-12-09Updated: 2023-10-16

Related Papers

Efficacy and safety of cofrogliptin once every 2 weeks in Chinese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled, phase 3 trial

Diabetes Obesity and Metabolism2024-10-215 citations